$HALB Halberd Corporation has acquired exclusive l
Post# of 42222
(Total Views: 119)
Posted On: 12/23/2020 6:58:18 AM
$HALB Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus’. The issued patents’ extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others.
(0)
(0)Scroll down for more posts ▼